NGS-based RNA-seq Market is expected to reach US$ 7,984.90 Million by 2027


PRESS RELEASE BY The Insight Partners 04 Jan 2019

Share this press on


Advancements in Sequencing Technology is anticipated to drive the market for NGS- based RNA- seq over the forecast period.

According to The Insight Partners market research study titled ‘NGS- Based RNA- Seq Market to 2027 - Global Analysis and Forecasts by Product & Services, Technology, Application and End User, the global NGS- based RNA- seq market was valued at US$ 1,240.87 Mn in 2017 and is estimated to reach US$ 7,984.90 Mn by 2027. The market is estimated to grow with a CAGR of 19.3% from 2018- 2027.The report highlights the trends prevalent in the global NGS- based RNA- seq market and the factors driving the market along with those that act as deterrents to its growth.

Global NGS- based RNA- seq market, based on the product & services is segmented into sample preparation, sequencing services, sequencing platform & consumables and data analysis, storage & management. The sample preparation segment is further bifurcated into method and workflow step segments. In 2017, sequencing platform & consumables segment held the largest share, by product& services. Additionally, the data analysis segment is anticipated to grow at a significant rate during the forecast period.

NGS-based RNA-seq Market

NGS-based RNA-seq Market


NGS Based RNA Seq Market Forecast, Trends, Scope by 2031

Download Free Sample

NGS Based RNA Seq Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product & Services (Sample Preparation, Sequencing Services, Sequencing Platform & Consumables and Data Analysis, Storage & Management), Technology (Sequencing by Synthesis, Nanopore Sequencing, Ion Semiconductor Sequencing and Single Molecule Real Time Sequencing), Application (Diagnostics, Drug Discovery, Precision Medicine and Others), End User (Biotechnology & Pharmaceutical Companies, Hospitals & Clinics, Research Centers and Academic & Government Institutes, and Others), and Geography



Global NGS- based RNA- seq market is expected to grow in the coming years, owing to the factors such as, reduced cost of genome sequencing, advancements in sequencing technology and next generation sequencing for cancer. However, the risks related to genetic data and high cost of NGS instruments is act as a restraint for this market. On the other hand, barcode scanning for long reads sequences likely to add novel opportunities for NGS- based RNA- seq market, in the coming years.

The major players operating in the NGS- based RNA- seq market include Illumina, Inc., Thermo Fisher Scientific Inc., Pacific Biosciences of California, Inc., Qaigen, F. Hoffmann- La Roche AG, Agilent Technologies, Inc., BGI, Oxford Nanopore Technologies, Perkinelmer, Inc. and Eurofins Scientific among others. The market players are focused towards bringing new and innovative product launches to sustain their position in the market. For instance, in October 2018, Agilent Technologies Inc. launched Agilent OnePGT, a genome- wide, next- generation sequencing (NGS) solution for preimplantation genetic testing (PGT).

The report segments the global NGS- based RNA- seq market as follows:

Global NGS- Based RNA- Seq Market - By Product & Services

  • Sample Preparation
  • Method 
  • Manual Method
  • Automated Method
  • Workflow Step
  • Library Preparation & Target Enrichment
  • Fragmentation, End Repair & Size Selection
  • Quality Control
  • Sequencing Services
  • Sequencing Platform & Consumables
  • Data Analysis, Storage & Management 

Global NGS- Based RNA- Seq Market - By Technology

  • Sequencing By Synthesis
  • Nanopore Sequencing
  • Ion Semiconductor Sequencing
  • Single-Molecule Real-Time (SMRT) Sequencing

Global NGS- Based RNA- Seq Market - By Application

  • Diagnostics
  • Drug Discovery
  • Precision Medicine
  • Others

Global NGS-Based RNA-Seq Market - By End User

  • Hospitals & Clinics
  • Research Centers and Academic & Government Institutes
  • Biotechnology & Pharmaceutical Companies
  • Others

Global NGS- Based RNA- Seq Market - By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
  • Asia Pacific (APAC)
    • Japan
    • China
    • India
  • Middle East & Africa (MEA)
    • U.A.E
    • Saudi Arabia
    • South Africa
  • South and Central America (SCAM)
    • Brazil

Contact Us

Phone: +1- 646- 491- 9876
Email Id: sales@theinsightpartners.com

Download Free PDF Brochure